openPR Logo
Press release

Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020

11-30-2017 01:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

Macro and Microeconomic Factors Continue to Impact Bacterial

Conjunctivitis also termed as pink eye in the United States and Madras eyes in India is caused due to infection or inflammation of the transparent membrane that covers the part of eyeball and inner surface of eyelids. The name Madras eye was originated in 20th century when adenovirus was discovered in India. Conjunctivitis is most commonly caused due to viral or bacterial infection, exposure to chemical or irritants or allergic reaction. Allergic conjunctivitis is known to be caused due to allergens such as cosmetic smoke, dust mites, pollen, perfumes and balsam of peru. Blurred vision, redness of eye, sensitivity to light, watering or itching of both the eyes, watery discharge from one or both the eyes and feeling of grittiness in one or both the eyes are the major symptoms witnessed in individuals suffering from conjunctivitis.

Report Overview and TOC @ https://www.transparencymarketresearch.com/bacterial-conjunctivitis-market.html

It is a highly contagious disease and is easily spread through sharing of objects like towel and poor washing of hands. The infection can also spread through sneezing or coughing. Thus, kids or adults diagnosed with pink eye are recommended not travel to public places for that period of time. However, conjunctivitis caused due to allergens (caused due to seasonal pollens, cosmetics and perfumes) or chemicals (chemicals, liquids such as furniture polish or bleach) are not contagious. Although, conjunctivitis caused by infections is highly contagious but it does not cause any serious health problem if diagnosed at an early stage. But, if the disease is left untreated then it can lead to permanent vision loss or other serious eye problem. Keratoconjunctivitis is a combination of conjunctivitis and inflammation of cornea while, blepharoconjunctivitis is a combination of inflammation of the cornea and conjunctivitis.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3771

Bacterial conjunctivitis is one of the major eye problem encountered worldwide and are caused by bacteria’s such as Moraxella and Chlamydia trachomatis. These bacteria’s are responsible for causing persistent conjunctivitis with higher level of redness. Similarly, Staphylococci and Streptococci are witnessed to cause non acute bacterial conjunctivitis. Moreover, bacteria’s such as β-hemolytic streptococci, Neisseria gonorrhoeae and Corynebacterium diphtheriae are other bacterias that are responsible for the production of membranes or psuedomembranes in bacterial conjunctivitis. Most of the cases of bacterial conjunctivitis are acute and self limiting and not a major cause of serious health problem however; due to its high prevalence the infection can have large impact on the society as individuals tend to miss their school or work. Thus, antibiotic, pills, ointment or eyedrops are given to clear the infection. Furthermore, if antibiotics are not showing proper response then swabs for bacterial culture are examined in the laboratories. Generally, fluoroquinolones, macrolides, amynoglycosides, phenicols are prescribed for the treatment of bacterial conjunctivitis. Similarly, tetracyclines or doxycycline are also prescribed for the treatment of infection caused due to Neisseria gonorrhoeae and Chlamydia trachomatis.

For Specific and Customized requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3771

Conjunctivitis is an extremely common condition with high incidence and low prevalence. The disease can be treated on its own. Hence, exact estimate of epidemlology of this disease is a challenge. However, as per the statistics published by government authority in the U.S approximately 5 million cases of bacterial conjunctivitis are reported due to increasing number of bacterial infections. Moreover, the treatment of disease in the U.S. accounts for approximately USD 589 million annually. It has also been witnessed that out of all the causes of conjunctivitis, bacterial conjunctivitis account for more than 50% of the cases. Thus, rising incidences of bacterial infection would drive the growth of this market.

Allergan, Inc., Merck, Pfizer, Inc., Novartis and others are some of the major players operating in this market segment.

Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=3771<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020 here

News-ID: 839914 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Bacterial

Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
Bacterial Vaginosis Drug Market is Growing Rapidly Due To Rising Awareness About …
Worldwide Market Reports added Latest Research Report titled "Global Bacterial Vaginosis Drug Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database. In this report, the global Bacterial Vaginosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Ask For Sample Copy
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as